My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$ENDP {{ '2015-11-05T14:45:36+0000' | timeago}} • Webcast

$ENDP's US Branded business delivered sales of $305MM, while US Generics business posted sales of $368MM contributing to YTD total growth of 32% vs. the prior year. International Pharmaceutical business is meeting the company's expectations and the strategic portfolio of this business is continuing.

User Jeffrey Molinaro {{ '2016-10-22T14:41:26+0000' | timeago}}

Can anyone answer some questions regarding the $WBA and $RAD M&A?

User John Yono {{ '2016-10-21T19:54:16+0000' | timeago}}

A merger between $TWX and $T? Huge! Apparently talks are going on and chances are it could go either way.

User Shawn Huston {{ '2016-10-21T19:39:13+0000' | timeago}}

$NFLX a monster move, going up. Expect making some money on Monday.

User Rick Mario {{ '2016-10-21T19:13:31+0000' | timeago}}

$AMD down more than 6% even after posting above consensus third quarter results.

User Carlton Davis {{ '2016-10-21T16:10:02+0000' | timeago}}

$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.

$EXP {{ '2016-10-24T12:43:40+0000' | timeago}} • Announcement

Gypsum wallboard and cement maker $EXP reported a rise in 2Q17 earnings driven by higher performance in its construction products and building materials businesses as well as lower costs and expenses. Net income grew to $60.24MM or $1.25 per share from $29.82MM or $0.59 per share last year. Revenues rose to $332.66MM from $329MM.

$KMB {{ '2016-10-24T12:42:03+0000' | timeago}} • Webcast

$KMB cut its 2016 organic sales growth outlook to 2%, compared to its prior expectation for growth at the low end of the 3-5% range. The company also reduced the upper end of its 2016 earnings outlook to $5.92-$6.05 per share from its previous outlook of $5.92-$6.15 per share.

$KMB {{ '2016-10-24T12:38:03+0000' | timeago}} • Webcast

$KMB said its ongoing restructuring is expected to be completed by the end of 2016, with total costs anticipated to be toward the high end of the previously communicated range of $130-$160MM after tax.

$KMB {{ '2016-10-24T12:36:21+0000' | timeago}} • Webcast

$KMB, known for brands like Kleenex, Scott, Huggies, Pull-Ups and Kotex, said its largest personal care segment revenue fell 2% to $2.3Bil. Revenue from consumer tissue segment decreased 4% to $2.5Bil. The sales were mainly impacted by forex rates.

$KMB {{ '2016-10-24T12:28:04+0000' | timeago}} • Webcast

Personal care products maker $KMB reported a higher quarterly profit on cost controls though forex pressured revenue. 3Q16 earnings per share rose to  $1.52 from  $1.41 a year ago. Net sales of $4.6Bil decreased approx. 3% compared to the year-ago period, as changes in foreign currency exchange rates reduced sales by more than 2%.